Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-26,257
Closed -$1.16M 337
2018
Q2
$1.16M Sell
26,257
-100,479
-79% -$4.63M 0.18% 183
2018
Q1
$5.8M Buy
+126,736
New +$6.3M 0.62% 38
2017
Q4
Sell
-67,993
Closed -$3.29M 473
2017
Q3
$3.29M Buy
+67,993
New +$3.38M 0.36% 93
2017
Q2
Sell
-5,286
Closed -$236K 790
2017
Q1
$236K Buy
+5,286
New +$220K 0.01% 830
2016
Q2
Sell
-158,252
Closed -$6.47M 1005
2016
Q1
$6.47M Buy
158,252
+93,456
+144% +$3.46M 0.39% 55
2015
Q4
$2.37M Buy
+64,796
New +$2.47M 0.19% 170
2014
Q3
Sell
-11,722
Closed -$475K 456
2014
Q2
$475K Buy
+11,722
New +$482K 0.24% 158
2013
Q3
Sell
-42,381
Closed -$1.3M 393
2013
Q2
$1.3M Buy
+42,381
New +$1.41M 0.42% 20

Other funds holding ORCL

Clinton Group's ORCL Position: Q3 2018 in Review

Clinton Group sold out of Oracle (ORCL) in Q3 2018, closing a stake of 26,257 shares — an estimated $1.16M sold.

Clinton Group first reported a position in ORCL in Q2 2013 and held it in 8 quarters. The position peaked at $6.47M in Q1 2016. 1,708 funds tracked by Wall St. Rank hold ORCL as of Q3 2018.

  • Clinton Group reported no remaining Oracle position as of Q3 2018 after selling out during the quarter.
  • Clinton Group sold 26,257 Oracle shares in Q3 2018, an estimated $1.16M.
  • Clinton Group first reported a position in Oracle in Q2 2013 and held it in 8 quarters.
  • Clinton Group's Oracle position peaked at $6.47M in Q1 2016.
  • 1,708 funds tracked by Wall St. Rank held Oracle as of Q3 2018.

Based on Clinton Group's 13F filing for Q3 2018, filed 10 Oct 2018.